Domain Associates is a private equity and venture capital firm that focuses on funding startups in the field of life sciences. The firm was founded in 1985 by Jesse I. Treu. Jim Blair has joined the firm since its inception and has remained as one of the firm’s partner as of February 2019. The firm’s current headquarters is located in New Jersey, but it also has offices in San Diego and Philadelphia.
In the past, the Domain Associates has invested in companies offering their business services in these fields: pharmaceuticals, diagnostics, and medical devices. The firm has also financed companies seeking various stages of funding: from incubation-stage startups to companies already at the stage of emerging growth
As of February 2019, the firm has raised more than $2.8 billion throughout its funding series. Its last funding series was launched in December 2016, and it managed to obtain $163.6 million. In December 2003 and April 2009 respectively, the firm succeeded in acquiring $500 million for each funding series.
Associated investment funds
A company focused on development of products to treat central nervous system disorders, pain and rare diseases
Oraya Therapeutics is a biotechnology company developing non-invasive therapies for eye diseases that is headquartered in San Francisco, California and was founded in 2007 by Michael Gertner.
A company developing therapies for inflammation and neurological diseases
A diagnostics company providing real-time biopsy material to guide personalized medicine for cancer patients
Antios Therapeutics is a biopharmaceutical company.
Milestone Pharmaceuticals is a Saint-Laurent, Quebec-based company.
Glaukos is a San Clemente, California-based healthcare company.
Carticept Medical is an Alpharetta, Georgia-based healthcare company.
Esperion Therapeutics is an Ann Arbor, Michigan-based company.
A company focused on the discovery and development of treatments for rare inherited diseases.
A company developing therapeutics for diseases
Altair Therapeutics was a biopharmaceutical company that focused on therapeutics to treat human respiratory diseases. It was founded in 2007 and is now closed.
A biotechnology company focused in the development of molecular therapies to treat heart failure
A company that designs and manufactures implantable products to treat presbyopia
A pharmaceutical company that develops therapies targeting solid and hematological cancer tumors
A company developing antithrombotic drug systems to treat acute and sub-acute cardiovascular and other indications
A compant developing nanoscale imaging and analytic platforms to analyze DNA
A life science devices company focused on the discovery and development of protein biomarkers as diagnostic tests
A diagnostics company offering genomic tests services
Jesse I. Treu
Documentaries, videos and podcasts